Both NF-κB cell signalling inhibition and the induction of oxidative stress are targets for eliminating AML LSCs [6, 9–11], confirming the ability of bithionol to reduce the number of AML stem-like cells. The gene discussed is NFKB1; the disease is acute myeloid leukemia.